Raffles PharmaTech Pte. Ltd.

Singapore CDMO founded in 2011, high-tech specialized in development, manufacturing and sales of high value-added APIs and pharmaceutical starting materials. Capabilities: organic synthesis, catalysis, organocatalysis, asymmetric synthesis, custom synthesis, contract research. cGMP equipment with cryogenic controls, high pressure reactors and OEB-4 containment.